Micropure Genomics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $675K

  • Investors
  • 3

Micropure Genomics General Information

Description

Operator of a biotechnology platform designed to simplify genomic sample preparation for sequencing. The company offers automated, end-to-end purification technology compatible with diverse sequencing workflows, enabling genomics researchers and healthcare laboratories to prepare high-quality DNA, RNA, and protein samples with greater efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5260 Fiore Terrace
  • Suite 1209
  • San Diego, CA 92122
  • United States
+1 (813)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 5260 Fiore Terrace
  • Suite 1209
  • San Diego, CA 92122
  • United States
+1 (813)

Micropure Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micropure Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 07-Jul-2026 $675K Completed Generating Revenue
5. Accelerator/Incubator 31-Oct-2025 Completed Generating Revenue
4. Grant 19-Sep-2025 Completed Generating Revenue
3. Grant 24-Jun-2025 Completed Generating Revenue
2. Grant 01-Jan-2023 $274K Completed Generating Revenue
1. Seed Round 25-Mar-2022 Completed Startup
To view Micropure Genomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Micropure Genomics Patents

Micropure Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024390803-A1 Systems, devices, and methods for processing biological samples Pending 27-Nov-2023
EP-4816808-A1 Systems, devices, and methods for processing biological samples Pending 27-Nov-2023
WO-2025117278-A1 Systems, devices, and methods for processing biological samples Inactive 27-Nov-2023 B01L3/502753

Micropure Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micropure Genomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EvoNexus Accelerator/Incubator Minority
National Institutes of Health Government
US National Science Foundation Accelerator/Incubator
To view Micropure Genomics’s complete investors history, request access »

Micropure Genomics FAQs

  • When was Micropure Genomics founded?

    Micropure Genomics was founded in 2021.

  • Where is Micropure Genomics headquartered?

    Micropure Genomics is headquartered in San Diego, CA.

  • What is the size of Micropure Genomics?

    Micropure Genomics has 7 total employees.

  • What industry is Micropure Genomics in?

    Micropure Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Micropure Genomics a private or public company?

    Micropure Genomics is a Private company.

  • What is Micropure Genomics’s current revenue?

    The current revenue for Micropure Genomics is .

  • How much funding has Micropure Genomics raised over time?

    Micropure Genomics has raised $675K.

  • Who are Micropure Genomics’s investors?

    EvoNexus, National Institutes of Health, and US National Science Foundation have invested in Micropure Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process